European Union new agreement with Pfizer and BioNTech could double coronavirus vaccine stocks, Bloomberg reports.
According to Bloomberg sources, the new contract would include 100 million doses of the vaccine as well as an option for another 200 million doses.
EU steps to secure new doses vaccine come a week after the European Commission decided to exercise its option to buy an additional 100 million doses of the coronavirus vaccine developed by Pfizer and BioNTech.
The European Commission has already ordered 200 million doses of this vaccine.
In total, the EU has signed agreements for 1.3 billion doses of vaccine with Pfizer / BioNTech, Moderna, Johnson & Johnson, AstraZeneca / Oxford, Sanofi / GSK and CureVac, with options to purchase another 660 million doses.